9ay9
From Proteopedia
(Difference between revisions)
m (Protected "9ay9" [edit=sysop:move=sysop]) |
|||
(One intermediate revision not shown.) | |||
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Co-crystal structure of human PRMT9 in complex with MRK-990 inhibitor== | |
- | + | <StructureSection load='9ay9' size='340' side='right'caption='[[9ay9]], [[Resolution|resolution]] 2.22Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[9ay9]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=9AY9 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=9AY9 FirstGlance]. <br> | |
- | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.22Å</td></tr> | |
- | [[Category: | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=A1AHM:(2~{R},3~{R},4~{S},5~{S})-2-(4-azanyl-5-methyl-pyrrolo[2,3-d]pyrimidin-7-yl)-5-[4-[(2-~{tert}-butylpyridin-3-yl)methylamino]butylsulfanylmethyl]oxolane-3,4-diol'>A1AHM</scene></td></tr> |
- | [[Category: | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=9ay9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=9ay9 OCA], [https://pdbe.org/9ay9 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=9ay9 RCSB], [https://www.ebi.ac.uk/pdbsum/9ay9 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=9ay9 ProSAT]</span></td></tr> |
- | [[Category: Arrowsmith | + | </table> |
- | [[Category: | + | == Function == |
- | [[Category: Dong | + | [https://www.uniprot.org/uniprot/ANM9_HUMAN ANM9_HUMAN] Arginine methyltransferase that can both catalyze the formation of omega-N monomethylarginine (MMA) and symmetrical dimethylarginine (sDMA). Specifically mediates the symmetrical dimethylation of SF3B2. Involved in the regulation of alternative splicing of pre-mRNA (PubMed:25737013, PubMed:25979344).<ref>PMID:25737013</ref> <ref>PMID:25979344</ref> |
- | [[Category: | + | == References == |
- | [[Category: | + | <references/> |
- | [[Category: | + | __TOC__ |
- | [[Category: | + | </StructureSection> |
- | [[Category: | + | [[Category: Homo sapiens]] |
- | [[Category: | + | [[Category: Large Structures]] |
- | [[Category: | + | [[Category: Arrowsmith CH]] |
- | [[Category: Nicholson | + | [[Category: Brown PJ]] |
- | [[Category: | + | [[Category: Dong A]] |
- | [[Category: | + | [[Category: Edwards AM]] |
- | [[Category: Siliphaivanh | + | [[Category: Fischer C]] |
- | [[Category: | + | [[Category: Gao YD]] |
- | [[Category: | + | [[Category: Halabelian L]] |
+ | [[Category: Hicks J]] | ||
+ | [[Category: Hutchinson A]] | ||
+ | [[Category: Li Y]] | ||
+ | [[Category: Nicholson B]] | ||
+ | [[Category: Schneider S]] | ||
+ | [[Category: Seitova A]] | ||
+ | [[Category: Siliphaivanh P]] | ||
+ | [[Category: Sloman D]] | ||
+ | [[Category: Zeng H]] |
Current revision
Co-crystal structure of human PRMT9 in complex with MRK-990 inhibitor
|
Categories: Homo sapiens | Large Structures | Arrowsmith CH | Brown PJ | Dong A | Edwards AM | Fischer C | Gao YD | Halabelian L | Hicks J | Hutchinson A | Li Y | Nicholson B | Schneider S | Seitova A | Siliphaivanh P | Sloman D | Zeng H